Fractyl Health (GUTS) Competitors $2.20 -0.07 (-3.08%) As of 02:04 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GUTS vs. TMCI, CLPT, OM, NNOX, NYXH, SMTI, ZIMV, STIM, TCMD, and SNWVShould you be buying Fractyl Health stock or one of its competitors? The main competitors of Fractyl Health include Treace Medical Concepts (TMCI), ClearPoint Neuro (CLPT), Outset Medical (OM), Nano-X Imaging (NNOX), Nyxoah (NYXH), Sanara MedTech (SMTI), ZimVie (ZIMV), Neuronetics (STIM), Tactile Systems Technology (TCMD), and SANUWAVE Health (SNWV). These companies are all part of the "medical equipment" industry. Fractyl Health vs. Its Competitors Treace Medical Concepts ClearPoint Neuro Outset Medical Nano-X Imaging Nyxoah Sanara MedTech ZimVie Neuronetics Tactile Systems Technology SANUWAVE Health Fractyl Health (NASDAQ:GUTS) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, analyst recommendations, valuation, community ranking, media sentiment, institutional ownership and profitability. Does the MarketBeat Community believe in GUTS or TMCI? Treace Medical Concepts received 21 more outperform votes than Fractyl Health when rated by MarketBeat users. However, 100.00% of users gave Fractyl Health an outperform vote while only 44.07% of users gave Treace Medical Concepts an outperform vote. CompanyUnderperformOutperformFractyl HealthOutperform Votes5100.00% Underperform VotesNo VotesTreace Medical ConceptsOutperform Votes2644.07% Underperform Votes3355.93% Do analysts rate GUTS or TMCI? Fractyl Health currently has a consensus target price of $11.00, suggesting a potential upside of 400.00%. Treace Medical Concepts has a consensus target price of $10.16, suggesting a potential upside of 70.14%. Given Fractyl Health's stronger consensus rating and higher possible upside, research analysts plainly believe Fractyl Health is more favorable than Treace Medical Concepts.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fractyl Health 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Treace Medical Concepts 0 Sell rating(s) 5 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.29 Which has more volatility and risk, GUTS or TMCI? Fractyl Health has a beta of 1.85, indicating that its share price is 85% more volatile than the S&P 500. Comparatively, Treace Medical Concepts has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500. Which has better earnings and valuation, GUTS or TMCI? Treace Medical Concepts has higher revenue and earnings than Fractyl Health. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFractyl Health$60K1,795.82-$77.09M-$1.85-1.19Treace Medical Concepts$210.82M1.78-$49.53M-$0.85-7.02 Is GUTS or TMCI more profitable? Treace Medical Concepts has a net margin of -30.33% compared to Fractyl Health's net margin of -64,849.48%. Fractyl Health's return on equity of 0.00% beat Treace Medical Concepts' return on equity.Company Net Margins Return on Equity Return on Assets Fractyl Health-64,849.48% N/A -57.21% Treace Medical Concepts -30.33%-51.12%-26.36% Does the media refer more to GUTS or TMCI? In the previous week, Treace Medical Concepts had 28 more articles in the media than Fractyl Health. MarketBeat recorded 29 mentions for Treace Medical Concepts and 1 mentions for Fractyl Health. Fractyl Health's average media sentiment score of 1.87 beat Treace Medical Concepts' score of 0.12 indicating that Fractyl Health is being referred to more favorably in the media. Company Overall Sentiment Fractyl Health Very Positive Treace Medical Concepts Neutral Do institutionals and insiders hold more shares of GUTS or TMCI? 84.1% of Treace Medical Concepts shares are owned by institutional investors. 27.7% of Treace Medical Concepts shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. SummaryTreace Medical Concepts beats Fractyl Health on 9 of the 17 factors compared between the two stocks. Get Fractyl Health News Delivered to You Automatically Sign up to receive the latest news and ratings for GUTS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GUTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GUTS vs. The Competition Export to ExcelMetricFractyl HealthSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$107.75M$4.37B$5.60B$8.63BDividend YieldN/A42.67%5.28%4.18%P/E Ratio-0.1829.0427.2520.01Price / Sales1,795.8271.08412.71157.94Price / CashN/A51.0838.2534.64Price / BookN/A5.827.124.70Net Income-$77.09M$67.63M$3.24B$248.05M7 Day Performance13.40%0.44%2.75%2.62%1 Month Performance28.65%15.30%9.00%6.32%1 Year Performance-63.93%18.37%31.41%13.78% Fractyl Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GUTSFractyl Health2.4093 of 5 stars$2.20-3.1%$11.00+400.0%-59.3%$107.75M$60K-0.18102Positive NewsTMCITreace Medical Concepts2.286 of 5 stars$5.74flat$10.16+77.0%+5.5%$360.99M$210.82M-5.80250CLPTClearPoint Neuro2.8191 of 5 stars$11.79-0.2%$25.00+112.0%+123.9%$329.99M$32.24M-17.09110Positive NewsInsider TradeOMOutset Medical1.7741 of 5 stars$17.81+1.4%$27.00+51.6%-68.1%$315.63M$115.27M-7.18520Positive NewsNNOXNano-X Imaging1.9229 of 5 stars$5.23+2.1%$9.50+81.6%-26.9%$302.18M$11.55M-6.15190Analyst RevisionNYXHNyxoah2.3193 of 5 stars$7.64-0.1%$14.50+89.8%-8.5%$260.22M$4.36M-4.09110Short Interest ↑Analyst RevisionSMTISanara MedTech2.1903 of 5 stars$29.09+0.3%$49.50+70.2%-6.6%$258.55M$91.57M-29.3860Positive NewsAnalyst RevisionZIMVZimVie3.0711 of 5 stars$9.01-1.4%$16.33+81.3%-42.6%$250.90M$443.55M-0.692,700Positive NewsSTIMNeuronetics2.1524 of 5 stars$3.81-2.6%$5.50+44.4%+90.0%$250.77M$89.45M-3.10180Positive NewsTCMDTactile Systems Technology3.8406 of 5 stars$9.89+0.1%$16.00+61.8%-17.3%$229.92M$293.16M14.13980Positive NewsSNWVSANUWAVE HealthN/A$26.24+0.2%N/AN/A$224.51M$36.19M-5.7540 Related Companies and Tools Related Companies Treace Medical Concepts Alternatives ClearPoint Neuro Alternatives Outset Medical Alternatives Nano-X Imaging Alternatives Nyxoah Alternatives Sanara MedTech Alternatives ZimVie Alternatives Neuronetics Alternatives Tactile Systems Technology Alternatives SANUWAVE Health Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GUTS) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fractyl Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fractyl Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
